{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:14:55Z","timestamp":1790187295675,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejogrb.2020.12.035","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T12:03:29Z","timestamp":1609243409000},"page":"174-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Breast cancer recurrence risk after hormonal contraceptive use in survivors of reproductive age"],"prefix":"10.1016","volume":"258","author":[{"given":"Molly K.","family":"Ostroot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Heslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.F.","family":"Kram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy A.","family":"Tjoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dorton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2020.12.035_bib0005","unstructured":"U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on November 2018 submission data (1999\u20132016): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Available at: www.cdc.gov\/cancer\/dataviz. Retrieved December 13, 2019."},{"key":"10.1016\/j.ejogrb.2020.12.035_bib0010","unstructured":"Centers for Disease Control and Prevention. Breast Cancer in Young Women. Available at: http:\/\/www.cdc.gov\/cancer\/breast\/young_women\/index.htm. Retrieved November 20, 2019."},{"key":"10.1016\/j.ejogrb.2020.12.035_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.contraception.2014.01.014","article-title":"Contraception after cancer treatment: describing methods, counseling, and unintended pregnancy risk","volume":"89","author":"Quinn","year":"2014","journal-title":"Contraception"},{"issue":"No. RR-3","key":"10.1016\/j.ejogrb.2020.12.035_bib0020","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.12.035_bib0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.5306\/wjco.v5.i4.693","article-title":"Caring for the breast cancer survivor\u2019s health and well-being","volume":"5","author":"Petra","year":"2014","journal-title":"World J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.12.035_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.fertnstert.2007.05.033","article-title":"Use of the levonorgestrel-releasing intrauterine system in breast cancer patients","volume":"90","author":"Trinh","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2020.12.035_bib0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.AOG.0000444440.96486.61","article-title":"Female age-related fertility decline. Committee opinion No. 589","volume":"123","author":"American College of Obstetricians and Gynecologists","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.12.035_bib0040","unstructured":"American Cancer Society. Cancer Facts and Figures 2020. Available at: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2020.html. Retrieved December 9, 2019."},{"key":"10.1016\/j.ejogrb.2020.12.035_bib0045","series-title":"AJCC Cancer staging manual","first-page":"587","article-title":"Breast","author":"Amin","year":"2018"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.12.035_bib0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11606-009-1023-8","article-title":"Contraception for cancer survivors","volume":"24","author":"Schwarz","year":"2009","journal-title":"J Gen Intern Med"},{"issue":"9017","key":"10.1016\/j.ejogrb.2020.12.035_bib0055","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ejogrb.2020.12.035_bib0060","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.12.035_bib0065","first-page":"65","article-title":"A prospective study of oral contraceptive use and risk of breast cancer (Nurses\u2019 Health Study, United States)","volume":"8","author":"Hankinson","year":"1997","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.12.035_bib0070","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2013.08.008","article-title":"Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study","volume":"88","author":"Vessey","year":"2013","journal-title":"Contraception"},{"issue":"7621","key":"10.1016\/j.ejogrb.2020.12.035_bib0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ejogrb.2020.12.035_bib0080","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1701-2163(16)32195-8","article-title":"Progesterone-only and non-hormonal contraception in the breast cancer survivor: joint review and committee opinion of the society of obstetricians and gynaecologists of Canada and the society of gynecologic oncologists of Canada","volume":"28","author":"McNaught","year":"2006","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.12.035_bib0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/oxfordjournals.aje.a010219","article-title":"Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen\/progestogen contraceptives","volume":"151","author":"Shapiro","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.ejogrb.2020.12.035_bib0090","first-page":"405","article-title":"The Cancer and steroid hormone study of the centers for disease control and the national institute of child health and human development","volume":"315","author":"Oral-contraceptive use and the risk of breast cancer","year":"1986","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.12.035_bib0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.1983.74","article-title":"Oral contraceptives and breast cancer: final report of an epidemiological study","volume":"47","author":"Vessey","year":"1983","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2020.12.035_bib0100","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet Gynecol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520308277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520308277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:51:46Z","timestamp":1759557106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520308277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":20,"alternative-id":["S0301211520308277"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.12.035","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer recurrence risk after hormonal contraceptive use in survivors of reproductive age","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}